aluates Reports

$ 0.0

Automative

Global Viral Vector Vaccines Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-30G10233

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028

BUY CHAPTERS

Global Viral Vector Vaccines Market Research Report 2025

Code: QYRE-Auto-30G10233

Report

September 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advanced Bioscience Laboratories

Boehringer Ingelheim

Brammer Bio

Creative Biogene

GE Healthcare

Pfizer Inc

Sanofi

Viral Vector Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Viral Vector Vaccines Market

The global market for Viral Vector Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Viral Vector Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Vaccines.

The Viral Vector Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vector Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Viral Vector Vaccines Market Report

Report Metric	Details
Report Name	Viral Vector Vaccines Market
CAGR	5%
Segment by Type	Adenovirus Fowlpox Virus Attenuated Yellow Fever Vaccinia Virus Vectors Others
Segment by Application	Hospitals Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Viral Vector Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Viral Vector Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Vector Vaccines Market report?

Ans: The main players in the Viral Vector Vaccines Market are Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer, Sanofi

What are the Application segmentation covered in the Viral Vector Vaccines Market report?

Ans: The Applications covered in the Viral Vector Vaccines Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Viral Vector Vaccines Market report?

Ans: The Types covered in the Viral Vector Vaccines Market report are Adenovirus, Fowlpox Virus, Attenuated Yellow Fever, Vaccinia Virus Vectors, Others

Recommended Reports

Vaccine Technology Markets

Influenza and General Vaccines

Pediatric and Preventive Vaccines

1 Viral Vector Vaccines Market Overview

1.1 Product Definition

1.2 Viral Vector Vaccines by Type

1.2.1 Global Viral Vector Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Adenovirus

1.2.3 Fowlpox Virus

1.2.4 Attenuated Yellow Fever

1.2.5 Vaccinia Virus Vectors

1.2.6 Others

1.3 Viral Vector Vaccines by Application

1.3.1 Global Viral Vector Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Viral Vector Vaccines Market Size Estimates and Forecasts

1.4.1 Global Viral Vector Vaccines Revenue 2020-2031

1.4.2 Global Viral Vector Vaccines Sales 2020-2031

1.4.3 Global Viral Vector Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Viral Vector Vaccines Market Competition by Manufacturers

2.1 Global Viral Vector Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Viral Vector Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Viral Vector Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Viral Vector Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Viral Vector Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Viral Vector Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Viral Vector Vaccines, Date of Enter into This Industry

2.8 Global Viral Vector Vaccines Market Competitive Situation and Trends

2.8.1 Global Viral Vector Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Viral Vector Vaccines Players Market Share by Revenue

2.8.3 Global Viral Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Viral Vector Vaccines Market Scenario by Region

3.1 Global Viral Vector Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Viral Vector Vaccines Sales by Region: 2020-2031

3.2.1 Global Viral Vector Vaccines Sales by Region: 2020-2025

3.2.2 Global Viral Vector Vaccines Sales by Region: 2026-2031

3.3 Global Viral Vector Vaccines Revenue by Region: 2020-2031

3.3.1 Global Viral Vector Vaccines Revenue by Region: 2020-2025

3.3.2 Global Viral Vector Vaccines Revenue by Region: 2026-2031

3.4 North America Viral Vector Vaccines Market Facts & Figures by Country

3.4.1 North America Viral Vector Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Viral Vector Vaccines Sales by Country (2020-2031)

3.4.3 North America Viral Vector Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Viral Vector Vaccines Market Facts & Figures by Country

3.5.1 Europe Viral Vector Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Viral Vector Vaccines Sales by Country (2020-2031)

3.5.3 Europe Viral Vector Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Viral Vector Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Viral Vector Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Viral Vector Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Viral Vector Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Viral Vector Vaccines Market Facts & Figures by Country

3.7.1 Latin America Viral Vector Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Viral Vector Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Viral Vector Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Viral Vector Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Viral Vector Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Viral Vector Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Viral Vector Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Viral Vector Vaccines Sales by Type (2020-2031)

4.1.1 Global Viral Vector Vaccines Sales by Type (2020-2025)

4.1.2 Global Viral Vector Vaccines Sales by Type (2026-2031)

4.1.3 Global Viral Vector Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Viral Vector Vaccines Revenue by Type (2020-2031)

4.2.1 Global Viral Vector Vaccines Revenue by Type (2020-2025)

4.2.2 Global Viral Vector Vaccines Revenue by Type (2026-2031)

4.2.3 Global Viral Vector Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Viral Vector Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Viral Vector Vaccines Sales by Application (2020-2031)

5.1.1 Global Viral Vector Vaccines Sales by Application (2020-2025)

5.1.2 Global Viral Vector Vaccines Sales by Application (2026-2031)

5.1.3 Global Viral Vector Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Viral Vector Vaccines Revenue by Application (2020-2031)

5.2.1 Global Viral Vector Vaccines Revenue by Application (2020-2025)

5.2.2 Global Viral Vector Vaccines Revenue by Application (2026-2031)

5.2.3 Global Viral Vector Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Viral Vector Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Advanced Bioscience Laboratories

6.1.1 Advanced Bioscience Laboratories Company Information

6.1.2 Advanced Bioscience Laboratories Description and Business Overview

6.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Advanced Bioscience Laboratories Viral Vector Vaccines Product Portfolio

6.1.5 Advanced Bioscience Laboratories Recent Developments/Updates

6.2 Boehringer Ingelheim

6.2.1 Boehringer Ingelheim Company Information

6.2.2 Boehringer Ingelheim Description and Business Overview

6.2.3 Boehringer Ingelheim Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boehringer Ingelheim Viral Vector Vaccines Product Portfolio

6.2.5 Boehringer Ingelheim Recent Developments/Updates

6.3 Brammer Bio

6.3.1 Brammer Bio Company Information

6.3.2 Brammer Bio Description and Business Overview

6.3.3 Brammer Bio Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Brammer Bio Viral Vector Vaccines Product Portfolio

6.3.5 Brammer Bio Recent Developments/Updates

6.4 Creative Biogene

6.4.1 Creative Biogene Company Information

6.4.2 Creative Biogene Description and Business Overview

6.4.3 Creative Biogene Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Creative Biogene Viral Vector Vaccines Product Portfolio

6.4.5 Creative Biogene Recent Developments/Updates

6.5 GE Healthcare

6.5.1 GE Healthcare Company Information

6.5.2 GE Healthcare Description and Business Overview

6.5.3 GE Healthcare Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GE Healthcare Viral Vector Vaccines Product Portfolio

6.5.5 GE Healthcare Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Company Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pfizer Viral Vector Vaccines Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Sanofi

6.7.1 Sanofi Company Information

6.7.2 Sanofi Description and Business Overview

6.7.3 Sanofi Viral Vector Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sanofi Viral Vector Vaccines Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Viral Vector Vaccines Industry Chain Analysis

7.2 Viral Vector Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Viral Vector Vaccines Production Mode & Process Analysis

7.4 Viral Vector Vaccines Sales and Marketing

7.4.1 Viral Vector Vaccines Sales Channels

7.4.2 Viral Vector Vaccines Distributors

7.5 Viral Vector Vaccines Customer Analysis

8 Viral Vector Vaccines Market Dynamics

8.1 Viral Vector Vaccines Industry Trends

8.2 Viral Vector Vaccines Market Drivers

8.3 Viral Vector Vaccines Market Challenges

8.4 Viral Vector Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Advanced Bioscience Laboratories

Boehringer Ingelheim

Brammer Bio

Creative Biogene

GE Healthcare

Pfizer Inc

Sanofi

List of Tables

Table 1. Global Viral Vector Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Viral Vector Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Viral Vector Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Viral Vector Vaccines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Viral Vector Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Viral Vector Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Viral Vector Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Viral Vector Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Viral Vector Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Viral Vector Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Viral Vector Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Viral Vector Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Viral Vector Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Viral Vector Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Viral Vector Vaccines Sales by Region (2020-2025) & (K Units)

Table 18. Global Viral Vector Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Viral Vector Vaccines Sales by Region (2026-2031) & (K Units)

Table 20. Global Viral Vector Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Viral Vector Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Viral Vector Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Viral Vector Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Viral Vector Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Viral Vector Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Viral Vector Vaccines Sales by Country (2020-2025) & (K Units)

Table 27. North America Viral Vector Vaccines Sales by Country (2026-2031) & (K Units)

Table 28. North America Viral Vector Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Viral Vector Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Viral Vector Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Viral Vector Vaccines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Viral Vector Vaccines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Viral Vector Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Viral Vector Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Viral Vector Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Viral Vector Vaccines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Viral Vector Vaccines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Viral Vector Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Viral Vector Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Viral Vector Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Viral Vector Vaccines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Viral Vector Vaccines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Viral Vector Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Viral Vector Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Viral Vector Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Viral Vector Vaccines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Viral Vector Vaccines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Viral Vector Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Viral Vector Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Viral Vector Vaccines Sales (K Units) by Type (2020-2025)

Table 51. Global Viral Vector Vaccines Sales (K Units) by Type (2026-2031)

Table 52. Global Viral Vector Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Viral Vector Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Viral Vector Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Viral Vector Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Viral Vector Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Viral Vector Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Viral Vector Vaccines Price (USD/Unit) by Type (2020-2025)

Table 59. Global Viral Vector Vaccines Price (USD/Unit) by Type (2026-2031)

Table 60. Global Viral Vector Vaccines Sales (K Units) by Application (2020-2025)

Table 61. Global Viral Vector Vaccines Sales (K Units) by Application (2026-2031)

Table 62. Global Viral Vector Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Viral Vector Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Viral Vector Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Viral Vector Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Viral Vector Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Viral Vector Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Viral Vector Vaccines Price (USD/Unit) by Application (2020-2025)

Table 69. Global Viral Vector Vaccines Price (USD/Unit) by Application (2026-2031)

Table 70. Advanced Bioscience Laboratories Company Information

Table 71. Advanced Bioscience Laboratories Description and Business Overview

Table 72. Advanced Bioscience Laboratories Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Advanced Bioscience Laboratories Viral Vector Vaccines Product

Table 74. Advanced Bioscience Laboratories Recent Developments/Updates

Table 75. Boehringer Ingelheim Company Information

Table 76. Boehringer Ingelheim Description and Business Overview

Table 77. Boehringer Ingelheim Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Boehringer Ingelheim Viral Vector Vaccines Product

Table 79. Boehringer Ingelheim Recent Developments/Updates

Table 80. Brammer Bio Company Information

Table 81. Brammer Bio Description and Business Overview

Table 82. Brammer Bio Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Brammer Bio Viral Vector Vaccines Product

Table 84. Brammer Bio Recent Developments/Updates

Table 85. Creative Biogene Company Information

Table 86. Creative Biogene Description and Business Overview

Table 87. Creative Biogene Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Creative Biogene Viral Vector Vaccines Product

Table 89. Creative Biogene Recent Developments/Updates

Table 90. GE Healthcare Company Information

Table 91. GE Healthcare Description and Business Overview

Table 92. GE Healthcare Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. GE Healthcare Viral Vector Vaccines Product

Table 94. GE Healthcare Recent Developments/Updates

Table 95. Pfizer Company Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Pfizer Viral Vector Vaccines Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Viral Vector Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Sanofi Viral Vector Vaccines Product

Table 104. Sanofi Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Viral Vector Vaccines Distributors List

Table 108. Viral Vector Vaccines Customers List

Table 109. Viral Vector Vaccines Market Trends

Table 110. Viral Vector Vaccines Market Drivers

Table 111. Viral Vector Vaccines Market Challenges

Table 112. Viral Vector Vaccines Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Viral Vector Vaccines

Figure 2. Global Viral Vector Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Viral Vector Vaccines Market Share by Type: 2024 & 2031

Figure 4. Adenovirus Product Picture

Figure 5. Fowlpox Virus Product Picture

Figure 6. Attenuated Yellow Fever Product Picture

Figure 7. Vaccinia Virus Vectors Product Picture

Figure 8. Others Product Picture

Figure 9. Global Viral Vector Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Viral Vector Vaccines Market Share by Application: 2024 & 2031

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Others

Figure 14. Global Viral Vector Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Viral Vector Vaccines Market Size (2020-2031) & (US$ Million)

Figure 16. Global Viral Vector Vaccines Sales (2020-2031) & (K Units)

Figure 17. Global Viral Vector Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 18. Viral Vector Vaccines Report Years Considered

Figure 19. Viral Vector Vaccines Sales Share by Manufacturers in 2024

Figure 20. Global Viral Vector Vaccines Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Viral Vector Vaccines Players: Market Share by Revenue in Viral Vector Vaccines in 2024

Figure 22. Viral Vector Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Viral Vector Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Viral Vector Vaccines Sales Market Share by Country (2020-2031)

Figure 25. North America Viral Vector Vaccines Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Viral Vector Vaccines Sales Market Share by Country (2020-2031)

Figure 29. Europe Viral Vector Vaccines Revenue Market Share by Country (2020-2031)

Figure 30. Germany Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Viral Vector Vaccines Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Viral Vector Vaccines Revenue Market Share by Region (2020-2031)

Figure 37. China Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Viral Vector Vaccines Sales Market Share by Country (2020-2031)

Figure 48. Latin America Viral Vector Vaccines Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Viral Vector Vaccines Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Viral Vector Vaccines Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Viral Vector Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Viral Vector Vaccines by Type (2020-2031)

Figure 58. Global Revenue Market Share of Viral Vector Vaccines by Type (2020-2031)

Figure 59. Global Viral Vector Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Viral Vector Vaccines by Application (2020-2031)

Figure 61. Global Revenue Market Share of Viral Vector Vaccines by Application (2020-2031)

Figure 62. Global Viral Vector Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 63. Viral Vector Vaccines Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Based Gene Therapy Market Research Report 2025

Viral Vector and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Virus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Development Service Market Research Report 2025

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global Viral Vector Manufacturing Services Market Research Report 2024

Viral and Non Viral Vector Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adenovirus Vector Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Genetic Vaccine Market Insights Forecast to 2030

Global Lentiviral Vectors Market Research Report 2024

Global Viral Vaccines Market Research Report 2025

Global Viral Arthritis Vaccine Market Research Report 2025

Global Poultry Viral Disease Vaccines Market Research Report 2024

Global Emerging Cancer Vaccines Market Insights Forecast to 2030

Global Viral Vector Manufacturing Market Research Report 2024

Global Viral Vectors Gene Therapy Market Research Report 2025

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccination Device Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions